CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Academy of Psychosematic Medicine

Academy of Psychosematic Medicine is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Decatur Vein Clinic

Decatur Vein Clinic is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Resources Network

Medical Resources Network is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Upfront Healthcare Services

Upfront`s Care Traffic Control platform proactively reassures and directs patients to the safest and most relevant care options within the health system.

Cunningham Drug Co Inc

Cunningham Drug Co Inc is a New Tazewell, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.